author-photo

Josep F. Nomdedeu

University of Barcelona

5

Papers

52

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia

2019 Blood
Show All
- Source
- Cite
- Save
Citations (43)
Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

2018 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Prognostic Impact of the Interaction between DNMT3A mutation and Internal Tandem Duplication of the FLT3 Gene (FLT3-ITD) in Patients with D e Novo Mutated NPM1 (NPM1mut) a cute Myeloid Leukemia

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
FLT3mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (4)